Clinical Trials Browser

NIH × Ondansetron × Lymphoid × Clear all

NCT00001337 2025-06-22

Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma

Phase 2 Completed

348 enrolled 15 charts

Burkitt Lymphoma, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic

NCT03030417 2024-12-10

Indenoisoquinoline LMP744 in Adults With Relapsed Solid Tumors and Lymphomas

Phase 1 Completed

36 enrolled 35 charts

Lymphoma